text.skipToContent text.skipToNavigation
Need help? Please contact us

CD8+ T cells

Naive CD8+ T cells drive the immune response by reacting to intracellular pathogens such as viruses with expansion and differentiation into cytotoxic effector cells. CD8+ T cells perform their cytotoxic function through the secretion of cytokines such as TNF-alpha and IFN-gamma or cytotoxic granules or through FasL/Fas interactions. During an infection, naive CD8+ T cells are primed by antigen-presenting cells (APCs) in secondary lymphoid organs such as lymph nodes (LN) and spleen. CD8+ T cells are MHC I-restricted; MHC class I molecules are expressed on the surface of all nucleated cells in an organism.  MHC class I proteins function to present “self” intracellular antigens. When cells become infected by intracellular pathogens, such as viruses, MHC class I proteins bind and display protein fragments (antigen) of the target pathogen on the cell surface. This helps T cells and other components of the immune system to identify and coordinate that the cell is destroyed. Cytotoxic CD8+ T cells of the adaptive immune system are the most powerful effectors in the anticancer immune response and constitute the backbone of cancer immunotherapy. 

CD8+ T cell subtype


Naïve CD8+ T cells can differentiate into effector or memory cell types. T cells activated to become effector cells differentiate into Tc1 or Tc2 cells. Tc1 cells can kill target cells directly or indirectly upon stimulation by cytokines such as IL-2 and IL-12. Additionally, cytotoxic Tc1 cells can release IFN-gamma or TNF-alpha for further modulation of immune responses. Tc2 T cells on the other hand modulate their function through the secretion of cytokines IL-4, IL-5, IL-10 and IL-13. In addition to these well-characterized subtypes, new subtypes such as Tc9, Tc17 and Tc22 have been identified, each activated  by and producing different cytokines (see diagram).